Additional file 2: of Dysnatremia, its correction, and mortality in patients undergoing continuous renal replacement therapy: a prospective observational study

Subject number according to the change of serum sodium during 24 or 72 hours. (DOC 38 kb

Additional file 3: Table S2. of Improving gastric cancer preclinical studies using diverse in vitro and in vivo model systems

Stage comparison according to ERBB2 expression in Asian (GEO accession: GSE36968). For comparisons, we used one-way ANOVA and Tukey’s test. In the Asian dataset, there were no significant differences between stages according to ERBB2 expression. (DOC 89 kb

Additional file 4: Figure S2A. of Improving gastric cancer preclinical studies using diverse in vitro and in vivo model systems

According to gastric cancer disease stage, ERBB2 expression in Asian (GEO accession: GSE36968) and Caucasian (GEO accession: GSE63288) datasets. a Box plots depicting ERBB2 expression in the Asian dataset (GEO accession: GSE36968). The x-axis represents stages and the y-axis is the logarithm of RPKM (a measure of gene expression). b Box plots depicting ERBB2 expression in the Caucasian dataset (GEO accession: GSE63288). The dataset did not contain stage IV patients. The x-axis represents GC disease stages and the y-axis is the logarithm of RPKMs. (DOC 88 kb

Additional file 1: Figure S1A. of Improving gastric cancer preclinical studies using diverse in vitro and in vivo model systems

Of 38 gastric cancer cell lines, we found that NCI-N87 cells, the basis for most preclinical anti-ERBB2 studies, had the highest ERBB2 expression level. (DOC 152 kb

Additional file 5: Table S3. of Improving gastric cancer preclinical studies using diverse in vitro and in vivo model systems

Stage comparison according to ERBB2 expression in Caucasian (GEO accession: GSE63288). For comparisons, we used one-way ANOVA and Tukey’s test. In the Caucasian dataset, there were significant stage differences according to ERBB2 expression. The significant p-value was in italic. (DOC 75 kb